{Reference Type}: Journal Article
{Title}: Dermatofibrosarcoma protuberans surgery: Experiences of four African surgical oncology units and literature review.
{Author}: Zongo N;Guigemdé RA;Yaméogo PB;Somé RO;Traore B;Dem A;
{Journal}: J Surg Oncol
{Volume}: 0
{Issue}: 0
{Year}: Aug 2022 23
{Factor}: 2.885
{DOI}: 10.1002/jso.27077
{Abstract}: <B>OBJECTIVE: </B>Dermatofibrosarcoma is a locally malignant tumor. This gives surgery a place of choice. The advent of imatinib has improved outcomes. Our aim is to describe the indications, techniques and results of surgery.<BR><B>METHODS: </B>A retrospective, multicenter, descriptive study conducted in four West African surgical oncology units. It covers dermatofibrosarcoma surgery performed between January 1, 1988 and December 31, 2020. We took into account the surgical procedure, the mode of skin coverage, adjuvant treatments and survival. Comparisons were possible using Student's t-test and Pearson's χ2 .<BR><B>RESULTS: </B>We recorded 81 cases of dermatofibrosarcoma. Surgery was effective in 90.1% of cases. Wide resection was the principle with a mean resection margin of 3.8 ± 1.9 cm. healing by primary intention, flaps and healing by secondary intention were the methods of skin coverage in 30.1%, 24.7% and 41.1% respectively. The type of skin coverage was related to the topography and size of the tumor (p < 0.0001). The healing time is associated with the type of skin cover. The recurrence rate was not related to the type of skin coverage (p = 0.8).<BR><B>CONCLUSIONS: </B>Wide and deep resection in the absence of Mohs micrographic surgery ensures healthy margins. Oncoplasty reduces the healing time without increasing the risk of recurrence.